We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRIO icon
101
DarioHealth
DRIO
$74.7M
$6.86M 0.2%
+18,735
New +$8.44M
CRIS icon
102
CALL
Curis
CRIS
$3.47M
$6.76M 0.19%
1,493
+1,015
+212% +$4.24M
MRNA icon
103
PUT
Moderna
MRNA
$25.4B
$6.63M 0.19%
+50,600
New +$7.33M
IMGN
104
DELISTED
Immunogen Inc
IMGN
$6.51M 0.19%
804,192
+188,906
+31% +$1.54M
HGEN
105
PUT
DELISTED
HUMANIGEN, INC.
HGEN
$6.5M 0.19%
+340,200
New +$6.21M
INNV icon
106
InnovAge Holding
INNV
$1.42B
$6.48M 0.18%
+251,225
New +$6.19M
TELA icon
107
TELA Bio
TELA
$32.4M
$6.28M 0.18%
421,202
+111,879
+36% +$1.68M
TNDM icon
108
PUT
Tandem Diabetes Care
TNDM
$1.63B
$6.25M 0.18%
+70,800
New +$6.58M
TMDX icon
109
PUT
Transmedics
TMDX
$3.02B
$6.22M 0.18%
+150,000
New +$4.62M
FOLD
110
CALL
DELISTED
Amicus Therapeutics
FOLD
$6.15M 0.18%
622,500
-177,500
-22% -$2.75M
XGN icon
111
Exagen
XGN
$159M
$5.79M 0.17%
+331,141
New +$5.9M
ARYD
112
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$5.7M 0.16%
+544,164
New +$5.88M
MGNX icon
113
CALL
MacroGenics
MGNX
$256M
$5.57M 0.16%
+175,000
New +$4.25M
RACB
114
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$5.47M 0.16%
+533,300
New +$5.46M
ITMR
115
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$5.46M 0.16%
+227,751
New +$5.42M
XENT
116
CALL
DELISTED
Intersect ENT, Inc
XENT
$5.36M 0.15%
256,800
+156,800
+157% +$3.62M
MRTX
117
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.18M 0.15%
30,242
+20,242
+202% +$4.01M
CDNA icon
118
PUT
CareDx
CDNA
$2.45B
$4.77M 0.14%
+70,000
New +$5.44M
SPKBU
119
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
$4.72M 0.13%
+475,000
New +$4.74M
HGEN
120
CALL
DELISTED
HUMANIGEN, INC.
HGEN
$4.68M 0.13%
+245,300
New +$4.48M
DCPH
121
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4.54M 0.13%
+101,200
New +$4.71M
CMAX
122
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$4.45M 0.13%
12,234
+147
+1% +$62.1K
SNCE
123
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.44M 0.13%
21,906
+1,906
+10% +$415K
ACRS icon
124
Aclaris Therapeutics
ACRS
$860M
$4.43M 0.13%
175,799
+125,799
+252% +$2.46M
ARQT icon
125
Arcutis Biotherapeutics
ARQT
$3.3B
$4.22M 0.12%
+145,744
New +$4.55M
3 4
5
6 7

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.